| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/29/2001 | EP1126828A1 Oral administration of adenosine analogs |
| 08/29/2001 | EP1126827A2 Controlled delivery of active agents |
| 08/29/2001 | EP1126826A1 Multiparticulate modified release composition |
| 08/29/2001 | EP1126824A1 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 08/29/2001 | EP1126822A1 Controlled release liquid delivery compositions with low initial drug burst |
| 08/29/2001 | EP1126821A1 Improved fast disintegrating tablet |
| 08/29/2001 | EP1126820A1 Controlled release drug delivery |
| 08/29/2001 | EP0914043A4 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 08/29/2001 | EP0892636B1 Ophthalmic solutions viscosified with tamarind seed polysaccharide |
| 08/29/2001 | EP0876141B1 Preparations of non-steroidal analgesics |
| 08/29/2001 | EP0810868B1 Use of piperine as a gastrointestinal absorption enhancer |
| 08/29/2001 | EP0730473B1 Hirudin conjugates from hirudin and lipophilic compounds |
| 08/29/2001 | CN1310759A Therapeutic and diagnostic domain 1 & beta 2GP1 polypeptides and methods of using same |
| 08/29/2001 | CN1310725A Carrangeenan compositions, and processes for their production |
| 08/29/2001 | CN1310631A Drug composites |
| 08/29/2001 | CN1310630A Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 08/29/2001 | CN1310627A Hair growth/maintenance compositions and methods involving the same |
| 08/29/2001 | CN1310626A Hybrid polypeptides with enhanced pharmacokinetic properties |
| 08/29/2001 | CN1310623A Bioimplant formulation |
| 08/29/2001 | CN1310617A Therapeutic system with addition of nacreous pigments |
| 08/29/2001 | CN1310616A Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 08/29/2001 | CN1310615A Estradiol-containing patch for transdermal administration of hormones |
| 08/29/2001 | CN1310613A Rapidly disintegrable solid preparation |
| 08/29/2001 | CN1310612A Novel particulate formulations |
| 08/29/2001 | CN1310611A Pressurized metered dose inhalers and pharmaceutical aerosol formulations |
| 08/29/2001 | CN1310025A Therapeutical compound and its application |
| 08/29/2001 | CN1070051C Substrate for medical plaster |
| 08/29/2001 | CA2337661A1 Stabilized granulocyte colony stimulating factor |
| 08/28/2001 | US6281376 Therapeutic compound—fatty acid conjugates |
| 08/28/2001 | US6281371 Lipopolyamines, and the preparation and use thereof |
| 08/28/2001 | US6281282 Adjustment ph; salt formation |
| 08/28/2001 | US6281239 Tissue softening composition containing urea and an antifungal composition |
| 08/28/2001 | US6281236 Containing allantoin and an emulsifier has improved stability coming from the adjustment of the ph to a range of 4.5 to 5.8. |
| 08/28/2001 | US6281225 Inhibiting proliferation of arterial smooth muscle cells |
| 08/28/2001 | US6281224 Benzalkonium chloride effective as a preservative, and tromethamine effective to keep the solution stable and clear and lowers eye irritation |
| 08/28/2001 | US6281202 Pharmaceutical compositions for treatment of EGF receptor associated cancers |
| 08/28/2001 | US6281195 Matrix-free osteogenic devices, implants and methods of use thereof |
| 08/28/2001 | US6281175 Medical emulsion for lubrication and delivery of drugs |
| 08/28/2001 | US6281015 Introducing a microsphere with a bioactive factor to a hepatocyte seeded biodegradable polymer matrix into a transplantation site; enhancing survival and proliferation of transplanted cells |
| 08/28/2001 | US6280773 Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative |
| 08/28/2001 | US6280772 Composition for slow release of active carboxy compound and polester of hydroxy acid, cooling and complexing |
| 08/28/2001 | US6280770 Microemulsions as solid dosage forms for oral administration |
| 08/28/2001 | US6280763 Apparatus and method for transdermal delivery of bupropion |
| 08/28/2001 | US6280761 Nicotine lozenge |
| 08/28/2001 | US6280752 For use in cosmetics and drugs |
| 08/28/2001 | US6280745 Pharmaceutical aqueous-gel composition comprising constitutive polymer selected from polyoxyalkylene block copolymers and/or polyethers, modifier polymer selected from cellulose ethers, sodium carboxymethylcellulose and polyacrylates, soap |
| 08/28/2001 | US6280744 Pharmaceutical composition which comprises pharmaceutical active agent and inorganic aerogel particles |
| 08/28/2001 | US6280742 Methods and materials for the treatment of prostatic carcinoma |
| 08/28/2001 | US6280736 Stable extract of Hypericum perforatum L.,process for preparing the same and pharmaceutical compositions |
| 08/28/2001 | US6280729 Treating christmas disease in patient by administering effective amount of therapeutic composition comprising storage stable aqueous solution of purified factor ix |
| 08/28/2001 | US6280716 Method for treating itching of the vagina |
| 08/28/2001 | US6280714 Lip care composition containing acexamic acid, and uses thereof |
| 08/28/2001 | US6280519 Environmentally preferred fluids and fluid blends |
| 08/28/2001 | CA2322579C Gelling ophthalmic compositions containing xanthan gum |
| 08/28/2001 | CA2217888C Triacetin as a transdermal penetration enhancer |
| 08/28/2001 | CA2178487C Local delivery of fibrinolysis enhancing agents |
| 08/28/2001 | CA2079902C Antibody conjugates for treatment of neoplastic disease |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001060890A2 Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 08/23/2001 | WO2001060868A1 Single phase gels for the prevention of adhesions |
| 08/23/2001 | WO2001060848A2 Conjugates targeted to target receptors |
| 08/23/2001 | WO2001060420A1 A medicinal aerosol formulation |
| 08/23/2001 | WO2001060417A2 Radioactive therapeutic liposomes |
| 08/23/2001 | WO2001060416A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 08/23/2001 | WO2001060415A1 Methods and compositions for gene delivery |
| 08/23/2001 | WO2001060412A2 Modification of biopolymers for improved drug delivery |
| 08/23/2001 | WO2001060411A1 Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance |
| 08/23/2001 | WO2001060409A1 Improved paste formulations |
| 08/23/2001 | WO2001060399A1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001060394A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | WO2001060393A1 Selective destruction of cells infected with human immunodeficiency virus |
| 08/23/2001 | WO2001060392A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | WO2001060382A1 Micelles |
| 08/23/2001 | WO2001060380A1 A parasiticidal formulation and a method of making this formulation |
| 08/23/2001 | WO2001060377A2 Methods for treatment of lysosomal storage diseases using biphosphonates |
| 08/23/2001 | WO2001060353A1 Liquid preparation with improved absorbability |
| 08/23/2001 | WO2001060348A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 08/23/2001 | WO2001060339A2 Method for the preparation of microspheres which contain colloidal systems |
| 08/23/2001 | WO2001060337A1 Compositions for topical delivery of a pharmaceutically active agent having reduced oxidation |
| 08/23/2001 | WO2001060336A1 Compositions for topical delivery of a pharmaceutically active agent having reduced skin irritation |
| 08/23/2001 | WO2001060335A2 Delivery systems using preformed biodegradable polymer compositions and methods |
| 08/23/2001 | WO2001060325A1 Pharmaceutical composition |
| 08/23/2001 | WO2001060171A1 Method of filtration of a dairy stream |
| 08/23/2001 | WO2001024807A3 Method for calming human beings using personal care compositions |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001022989A3 Method to enhance healing of sternum after sternotomy |
| 08/23/2001 | WO2001014325A3 Branched, substantially unsaturated fatty alcohol sulfates |
| 08/23/2001 | WO2001012159A3 Artificial tear replacement solution |
| 08/23/2001 | WO2001008704A3 Dendrimer-photosensitizer complexes for medical applications |
| 08/23/2001 | WO2000072883A3 Pharmaceutical transdermal compositions |
| 08/23/2001 | US20010016643 Peptide derivatives |
| 08/23/2001 | US20010016624 Target proteins or drugs covalently linked to the hydrogels for controlled release; polymer backbone having a degradable linkage, a first acrylated terminus, and a second terminus comprising a target or target coupling group |
| 08/23/2001 | US20010016604 Mixing a cosmetic or pharmaceutical agent in a vehicle for topical administration to the skin of humans or animals with hydroxycarboxylic acid and related ketocarboxylic acid and ester, lactone or salt forms |
| 08/23/2001 | US20010016603 Calcium formate for use as a dietary supplement |
| 08/23/2001 | US20010016587 Contrast agents |
| 08/23/2001 | US20010016577 Aqueous liquid containing active ingredient, clay, and a gum; protective coatings; retention; nausea, heartburn, diarrhea; side effect reduction |
| 08/23/2001 | US20010016220 Core of dietary fiber surrounded by biologically active subtance such as probiotic microorgansims and a shell forming substance; bioavailability |
| 08/23/2001 | US20010016196 Immunoliposomes that optimize internalization into target cells |
| 08/23/2001 | DE10038110A1 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |